{"disease":{"id":"hypoglycemic-agents","name":"hypoglycemic agents"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04809220","title":"A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":591,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT06145360","title":"Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"SINA Health Education and Welfare Trust","has_results":false},{"nct_id":"NCT03639545","title":"The Effects of Empagliflozin on Arterial Wall Characteristics","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false},{"nct_id":"NCT04371978","title":"Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":64,"lead_sponsor_name":"Rabin Medical Center","has_results":false},{"nct_id":"NCT03578991","title":"Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Parc Sanitari Pere Virgili","has_results":false},{"nct_id":"NCT03646292","title":"Antidiabetic Drugs for Steatotic Liver Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT04443777","title":"Analysis of Ergogenic Potential and Risks Associated With Acute and Chronic Use of Sulphonylureas on Physical Exercise","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":44,"lead_sponsor_name":"Instituto de Cardiologia do Rio Grande do Sul","has_results":false},{"nct_id":"NCT03852901","title":"Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"National Institute on Aging (NIA)","has_results":true}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}